Literature DB >> 4014309

Partial deletion of distal 17q.

J Bridge, W Sanger, G Mosher, B Buehler, R Nelson, M Welsh, J Newland, M Kafka.   

Abstract

A newborn female was found to have a deletion of the terminal portion of 17q. Prominent manifestations included microcephaly, apparent hypertelorism, epicanthic folds, a broad nasal bridge with anteverted nostrils, posteriorly angulated ears, micrognathia, widely spaced nipples, arachnodactyly with proximal thumbs, and a coxa vara deformity. The unbalanced translocation was inherited from the mother, who had a reciprocal translocation involving the terminal portions of 2p and 17q. To the best of our knowledge, this is the first report of a liveborn infant with deletion of the distal portion of 17q with the exception of reports of patients with ring chromosome 17.

Entities:  

Mesh:

Year:  1985        PMID: 4014309     DOI: 10.1002/ajmg.1320210204

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  5 in total

1.  Miller-Dieker syndrome with ring chromosome 17.

Authors:  N Sharief; J Craze; D Summers; L Butler; C B Wood
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

Review 2.  Mendelian cytogenetics. Chromosome rearrangements associated with mendelian disorders.

Authors:  N Tommerup
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

Review 3.  The molecular genetics of human sex determination.

Authors:  U Wolf
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

4.  Del(18p) shown to be a cryptic translocation using a multiprobe FISH assay for subtelomeric chromosome rearrangements.

Authors:  S W Horsley; S J Knight; J Nixon; S Huson; M Fitchett; R A Boone; D Hilton-Jones; J Flint; L Kearney
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

5.  A de novo translocation t(3;17)(q26.3;q23.1) in a child with Cornelia de Lange syndrome.

Authors:  M Ireland; C English; I Cross; W T Houlsby; J Burn
Journal:  J Med Genet       Date:  1991-09       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.